Sanger sequencing and cloning of BTKCys481 mutants

LX Lian Xu
NT Nicholas Tsakmaklis
GY Guang Yang
JC Jiaji G. Chen
XL Xia Liu
MD Maria Demos
AK Amanda Kofides
CP Christopher J. Patterson
KM Kirsten Meid
JG Joshua Gustine
TD Toni Dubeau
MP M. Lia Palomba
RA Ranjana Advani
JC Jorge J. Castillo
RF Richard R. Furman
ZH Zachary R. Hunter
ST Steven P. Treon
request Request a Protocol
ask Ask a question
Favorite

A 382 bp fragment covering the BTKCys481 was amplified by PCR. The forward and reverse PCR primers were 5′-TGAGAAGCTGGTGCAGTTGTATG-3′ and 5′-CTGGAGATATTTGATGGGCTCAG-3′, respectively. The amplified PCR products were isolated by QIAquick Gel Extraction Kit (Qiagen, Valencia, CA), and sequenced using forward and reverse PCR primers. PCR products were cloned into the TA cloning vector, and selected colonies sequenced using the M13 primers (Genewiz, South Plainfield, NJ).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A